Colon cancer drug that ‘shrinked 60% of tumors’ is being hailed as a ‘game-changer’
A COMBINATION of two immunotherapy drugs could be used to treat the most common form of bowel cancer, scientists say. ‘Incredibly exciting’ studies found that tumors had shrunk or remained stable in three out of five patients. Scientists have hailed a ‘groundbreaking’ new combination of immunotherapy drugs to treat bowel cancerCredit: Getty – Contributor Botensilimab … Read more
